Business Description
Becton, Dickinson and Co
NAICS : 339112
SIC : 3841
ISIN : US0758874061
Share Class Description:
BDXB.PFD: PRF PERPETUAL USD 50 - 1/20TH INT Ser BCompare
Compare
Traded in other countries / regions
BDX.USA0R19.UKBOX.GermanyB1DX34.BrazilBDX.Mexico1BDX.ItalyBDX.AustriaBDX.SwitzerlandBDX-RM.Russia IPO Date
2020-05-20Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.75 | |||||
| Debt-to-EBITDA | 4.35 | |||||
| Interest Coverage | 5.24 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.4 | |||||
| Beneish M-Score | -2.6 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.7 | |||||
| 3-Year EBITDA Growth Rate | 12.1 | |||||
| 3-Year EPS without NRI Growth Rate | 87.7 | |||||
| 3-Year FCF Growth Rate | -9.2 | |||||
| 3-Year Book Growth Rate | 2.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 8.65 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.77 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 2.39 | |||||
| 12-1 Month Momentum % | -2.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.85 | |||||
| Quick Ratio | 1.36 | |||||
| Cash Ratio | 0.8 | |||||
| Days Inventory | 105.79 | |||||
| Days Sales Outstanding | 45.54 | |||||
| Days Payable | 52.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 4.8 | |||||
| Shareholder Yield % | 1.67 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.06 | |||||
| Operating Margin % | 12.85 | |||||
| Net Margin % | 7.13 | |||||
| ROE % | 5.49 | |||||
| ROA % | 2.64 | |||||
| ROIC % | 4.83 | |||||
| 3-Year ROIIC % | -667.75 | |||||
| ROC (Joel Greenblatt) % | 25.73 | |||||
| ROCE % | 4.64 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 48.87 | |||||
| Forward PE Ratio | 29.79 | |||||
| PE Ratio without NRI | 21.11 | |||||
| Shiller PE Ratio | 46.2 | |||||
| Price-to-Owner-Earnings | 25.54 | |||||
| PEG Ratio | 11.11 | |||||
| PS Ratio | 3.49 | |||||
| PB Ratio | 2.65 | |||||
| Price-to-Free-Cash-Flow | 21.52 | |||||
| Price-to-Operating-Cash-Flow | 17.58 | |||||
| EV-to-EBIT | 38.29 | |||||
| EV-to-EBITDA | 18.59 | |||||
| EV-to-Revenue | 4.17 | |||||
| EV-to-FCF | 25.66 | |||||
| Earnings Yield (Greenblatt) % | 2.61 | |||||
| FCF Yield % | 4.69 | |||||
| Forward Rate of Return (Yacktman) % | 6.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BDXB.PFD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Becton, Dickinson and Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 10.84 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.6625 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | -2.15 | ||
| 52-Week Range ($) | 45.85 - 52.52 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Becton, Dickinson and Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Becton, Dickinson and Co Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Becton, Dickinson and Co Frequently Asked Questions
What is Becton, Dickinson and Co(BDXB.PFD)'s stock price today?
The current price of BDXB.PFD is $48.16. The 52 week high of BDXB.PFD is $52.52 and 52 week low is $45.85.
When is next earnings date of Becton, Dickinson and Co(BDXB.PFD)?
The next earnings date of Becton, Dickinson and Co(BDXB.PFD) is 2024-11-07.
Does Becton, Dickinson and Co(BDXB.PFD) pay dividends? If so, how much?
Becton, Dickinson and Co(BDXB.PFD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers